In response to the market demand, Indian drugmakers, including Cipla, are actively developing generic versions of these weight-loss drugs to secure a larger market share in India, which is the world's most populous country.
May 13, 2024
As India and Nepal grapple with the growing burden of cancer cases, initiatives like these are pivotal in steering the healthcare landscape towards innovative solutions and improved patient care
Nov 04, 2023
The integration of KIMS into the QCIL network marks a new chapter in the healthcare landscape. The increased bed capacity and the solid financial outlook indicate a promising future for Quality Care under Blackstone's ownership, solidifying its role as a major player in the healthcare sector.
Oct 26, 2023
Manipal HealthMap highlighted that the acquisition will expand its footprint by adding 23 new centres to its Manipal TRUtest network. This network, post-acquisition, will comprise over 100 centers, serving a vast customer base exceeding 50 lahks across 16 states.
Oct 19, 2023
$1 billion of the $1.915 billion total will be donated by the World Bank to help India's health sector prepare for pandemics and improve the delivery of healthcare services. Two complementary loans totaling $500 million each make up the $1 billion loans.
Jul 08, 2022
Medicircle unleashes VROZART Health in delivering top-class services in the health care sector. VROZART Health brings healthcare at ease which helps you choosing treatments as per your ease and convenience
Aug 06, 2021
Interchangeable Designation Allows Substitution at the Pharmacy Counter for Lantus Across the U.S. to Help Increase Access to Medicines for People Living with Diabetes
Jul 29, 2021
Interchangeable Designation Allows Substitution at the Pharmacy Counter for Lantus Across the U.S. to Help Increase Access to Medicines for People Living with Diabetes
Jul 29, 2021
“Numerous studies have shown long-term survival improvements with the Opdivo plus Yervoy combinationacross various tumor types, bringing benefit to patients around the world".
Jul 17, 2021
As discussed during our Capital Markets Day in February, simplifying the CHC product portfolio is an important part of our strategy to focus our resources and efforts where we can bring the most value, especially to consumers.
Jul 14, 2021
In a two-stage approach, the study will initially investigate the efficacy of a vaccine formulation targeting the original virus strain (D.614), while a second stage will evaluate a second formulation targeting the Beta variant (B.1.351)
Jul 09, 2021
2-DG is yet another addition to our COVID-19 portfolio that already covers the full spectrum of mild to moderate and severe conditions and includes a vaccine. We are extremely pleased to have partnered with DRDO in our collective fight against the COVID-19 pandemic.
Jun 28, 2021
2-DG is yet another addition to our COVID-19 portfolio that already covers the full spectrum of mild to moderate and severe conditions and includes a vaccine. We are extremely pleased to have partnered with DRDO in our collective fight against the COVID-19 pandemic.
Jun 28, 2021
Recommendation based on positive results from the Phase 3 CheckMate -577 trial in which Opdivo doubled disease-free survival compared to placebo in the all-randomized population
Jun 25, 2021
“We look forward to the European Commission’s decision as we build on our innovative multiple myeloma and cell therapy research to offer novel and personalized treatment options for patients in need.â€
Jun 25, 2021
"By combining enzalutamide, which has a proven clinical benefit in men with metastatic castration-sensitive prostate cancer, with talazoparib, our PARP inhibitor that is active in DDR-mutated cancer, we may be able to offer a new treatment option that targets the underlying genetic mechanisms associated with DDR-mutated mCSPC.â€
Jun 23, 2021
This approval follows a priority review designation by the Center for Drug Evaluation of China’s National Medical Products Administration (NMPA) and marks the first global regulatory approval for the oral, potent, and highly selective MET tyrosine kinase inhibitor
Jun 23, 2021
Brovana® is a long-acting beta-2 adrenergic agonist (beta-2 agonist) indicated for treatment of bronchoconstriction in patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema.
Jun 23, 2021
Halozyme’s drug delivery technology provides the opportunity to administer large volume subcutaneous injections that may enable dosing intervals of every three months and up to six months or longer for ViiV’s pipeline of HIV medicines
Jun 22, 2021
The approval confirms Aubagio as the first oral multiple sclerosis (MS) therapy for first-line treatment of children and adolescents with MS in the European Union.
Jun 19, 2021
Testosterone Topical Solution USP, 30 mg per pump actuation is indicated for replacement therapy in males for conditions associated with a deficiency or absence of endogenous testosterone
Jun 17, 2021
It is important to note that tofacitinib has not been approved or authorized for use by any regulatory authority worldwide for the treatment of COVID-19 and tofacitinib should not be used in patients with an active serious infection.
Jun 17, 2021
By virtue of the settlement, NATCO and Breckenridge have been granted a license permitting the launch of their generic carfilzomib products on a date that is held as confidential in the year 2027 or sooner depending on certain occurrences.
Jun 14, 2021
Molnupiravir, the antiviral drug was initially developed for the treatment of influenza and is repurposed to completely suppress the COVID virus transmission within 24 hours.
Jun 11, 2021
“The positive evidence from the CADENZA trial demonstrate significant improvements in hemolysis and meaningful impact on key measures of anemia and fatigue.â€
Jun 11, 2021
These doses are part of Pfizer and BioNTech’s previously announced pledge to provide two billion doses of the COVID-19 vaccine to low- and middle-income countries over the next 18 months.
Jun 10, 2021
“In addition to this agreement with the U.S. government, we are actively engaged in numerous efforts to make molnupiravir available globally to fulfill Merck’s commitment to widespread access†said Rob Davis, president, Merck.
Jun 09, 2021
In 2018, the FDA approved LORBRENA for the treatment of patients with ALK-positive metastatic NSCLC whose disease has progressed on crizotinib and at least one other ALK inhibitor for metastatic disease
Mar 05, 2021
While the pseudovirus system used is a surrogate for authentic SARS-CoV-2, previous studies have shown excellent concordance between pseudotype neutralization and SARS-CoV-2 neutralization assays.
Jan 21, 2021
GSK plc announced updated data from GARNET cohort F evaluating dostarlimab in mismatch repair-deficient non-endometrial advanced solid cancers being presented today at the 2021 American Society of Clinical Oncology Gastrointestinal Cancers Symposium
Jan 18, 2021
“This collaboration with Jubilant Therapeutics will further advance our comprehensive research efforts to find therapeutics to diminish cytokine storms and decrease COVID-19 symptom gravity,†said Yulia Nefedova.
Jan 16, 2021
“Today’s authorisation is a really important milestone towards enabling children to have access to age-appropriate formulations of HIV medicine," said Deborah Waterhouse, CEO of ViiV Healthcare
Jan 13, 2021
Through PBGI, Pfizer is investing up to $500 million in biotechnology companies, providing funding and access to Pfizer’s scientific expertise to help ensure the continuity of promising clinical development programs of potential future strategic interest to Pfizer.
Jan 13, 2021
Vir Biotechnology, Inc. and GlaxoSmithKline plc today announced an agreement with the U.K.-based AGILE initiative to evaluate VIR-7832 in patients with mild to moderate COVID-19 in Phase 1b/2a clinical trial
Jan 12, 2021
Merck announced the U.S. FDA accepted for priority review a Biologics License Application for V114, Merck’s investigational 15-valent pneumococcal conjugate vaccine, for the prevention of invasive pneumococcal disease.
Jan 12, 2021
The application includes data for a new, 50 mg tablet that can be dispersed in water and which was developed to facilitate use in children, who are disproportionately affected by the disease.
Jan 08, 2021
AstraZeneca’s COVID-19 vaccine has been granted emergency use authorization in India as well as Argentina, Dominican Republic, El Salvador, Mexico and Morocco for the active immunization of adults.
Jan 07, 2021
Empagliflozin and Metformin Hydrochloride Extended-Release (ER) Tablets, are indicated as an adjunct to diet and exercise, to improve glycemic control in adults with type 2 diabetes mellitus when treatment with both empagliflozin and metformin hydrochloride is appropriate.
Jan 07, 2021
Pfizer inc. and OPKO Health Inc. announced today that the USFDA has accepted for filing the initial Biologics License Application for somatrogon, a long-acting human growth hormone for the treatment of pediatric patients with growth hormone deficiency.
Jan 05, 2021
“The EMA’s decision to validate our application represents important progress for the esophageal cancer community, and we look forward to potentially bringing Opdivo to patients in the EU who may benefit.â€
Jan 05, 2021
Preliminary data from the non-powered U.S. Phase 2 study of 40 hospitalized patients shows that orally-administered opaganib was safe, with no material safety differences between opaganib and control arms
Jan 02, 2021
LORBRENA is a third-generation ALK inhibitor specifically developed to inhibit the most common tumour mutations that drive resistance to current medications and to address brain metastases
Dec 29, 2020
“With these 100 million additional doses, the United States will be able to protect more individuals and hopefully end this devastating pandemic more quickly,†said Albert Bourla, Chairman and Chief Executive Officer, Pfizer.
Dec 24, 2020
“Glioblastoma is an aggressive cancer with a very poor prognosis that has seen limited new treatment options over the last 15 years,†said Michael Mandola, Ph.D., Oncology Development Program Lead, Bristol Myers Squibb.
Dec 23, 2020
"Building upon the promising clinical findings to date for MK-7110, Merck is pleased to be collaborating with the U.S. Government to advance the manufacture and distribution of this candidate for patients with serious COVID-19 disease," said Dr. Roger M. Perlmutter, president, Merck Research Lab.
Dec 23, 2020
“We are excited to partner with Menarini for Ryaltris™ across Europe as they have a proven track record in partnering and commercializing respiratory products in the region, " said Achin Gupta, Executive Vice President, Business Head EMEA-L, Glenmark Pharmaceuticals
Dec 23, 2020
This authorization represents the first time people living with HIV in Europe may be able to receive a long-acting injectable treatment that removes the need to take daily oral tablets
Dec 21, 2020
BENLYSTA is the first medicine approved to treat systemic lupus and adults with active lupus nephritis, an important treatment advance for patients with this incurable autoimmune disease.
Dec 18, 2020
This new dosing option is consistent with the approved Imfinzi dosing in extensive-stage small cell lung cancer and once approved, will be available to patients with locally advanced, unresectable NSCLC weighing more than 30kg.
Dec 15, 2020
Phase 2 trials in 1,200 adults, young children, and infants suggest new poliovirus vaccine may have the potential to overcome outbreaks caused by a mutated polio strain linked to the oral vaccine that typically circulates in areas of low immunisation coverage, and poses one of biggest barriers to eradication
Dec 12, 2020
“Patients in Europe with MSI-H/dMMR colorectal cancer have had only chemotherapy-containing regimens available to them in the first-line treatment setting and have historically faced poor outcomes,†said Dr. Vicki Goodman.
Dec 11, 2020
The FDA’s acceptance of our application for 20vPnC is yet another significant milestone in Pfizer’s continuing efforts to help protect adults against pneumococcal disease,†said Kathrin U. Jansen, Ph.D., Senior Vice President and Head of Vaccine Research and Development, Pfizer.
Dec 09, 2020
"We believe JBI-802 could one day serve as a powerful therapeutic agent for the treatment of specific cancers, including myelodysplastic syndrome, select acute myeloid leukemia and solid tumor subsets.â€
Dec 08, 2020
We continue to be encouraged by the findings from this Phase 1/2 study, which now include durable factor VIII expression through one year of follow-up, and we look forward to continuing to follow these patients
Dec 07, 2020
PureTech’s global, randomized, double-blind, placebo-controlled Phase 2 trial is designed to evaluate the efficacy, safety and tolerability of LYT-100 in adults with post-acute COVID-19 respiratory complications
Dec 05, 2020
The Alliance is a collaborative network of leading cancer centers that work together to advance comprehensive cancer profiling and establish standards of care for molecular testing in oncology through research
Dec 01, 2020
Objective of the study is to assess the efficacy of Carragelose nasal and throat spray in reducing the rate, severity, and duration of COVID-19 infections
Dec 01, 2020
Atopic dermatitis is a chronic inflammatory disease of the skin that can be debilitating, and severe disease can significantly impact many aspects of life for both children and their families.
Nov 30, 2020
Hon'ble Prime Minister's leadership vision, in-depth understanding and knowledge of the facts guided us in facilitating the interactions and discussions on the vaccines and therapeutics for COVID-19
Nov 30, 2020
DJSI is one of the world’s most respected and widely accepted sustainability benchmarks globally with only the top-ranked companies in terms of Corporate Sustainability within each industry featured in the index.
Nov 26, 2020
Senhwa announces multiple IND application submissions to US FDA and Health Canada evaluating its investigational drug, CX-5461, for the treatment of patients with solid tumours with BRCA2 or PALB2 mutations
Nov 26, 2020
Piramal Sarvajal, the safe drinking water initiative of Piramal Foundation launched a tool named Composite Water Vulnerability Index at its recent Webinar on ‘Sustainable Water Security for Urban Under-Served’.
Nov 25, 2020
The vaccine's clinical study not only provides key data for the launch of the vaccine in China, but also may play a positive role in the widespread promotion and use of the vaccine throughout Asia and around the world
Nov 25, 2020
The oral antiviral medication Favipiravir, which prevents the replication phase of the virus life-cycle, leads to significant improvement in clinical cure in patients with mild to moderate COVID-19.
Nov 23, 2020
“The results from the CROWN trial demonstrate that LORBRENA has the potential to be a practice-changing, first-line option, and we thank the many people and their families who participated in this trial.â€
Nov 19, 2020
The approval was based on the results of Phase III and Phase II clinical studies conducted globally to evaluate Fycompa as an adjunctive therapy in pediatric patients with POS or PGTCS
Nov 16, 2020
This initiative supports pharmaceutical companies by providing them for free with the necessary tools to protect COVID-19 relevant medicines and vaccines against counterfeiting
Nov 13, 2020
AstraZeneca and Amgen today announced positive results from the new medicine tezepelumab in patients with severe, uncontrolled asthma.
Nov 10, 2020
“Today is a great day for science and humanity. The first set of results from our Phase 3 COVID-19 vaccine trial provides the initial evidence of our vaccine’s ability to prevent COVID-19,†said Dr. Albert Bourla
Nov 09, 2020
Dr. Reddy’s announced its partnership with Biotechnology Industry Research Assistance Council, Department of Biotechnology, Government of India, for advisory support on clinical trials of Sputnik V vaccine in India.
Oct 29, 2020
The agreement covers the gene therapy program targeting OTOF (OTOF-GT), the gene encoding the otoferlin protein. Mutations in OTOF lead to severe or profound congenital hearing loss
Oct 28, 2020
“Atopic dermatitis is a serious, unpredictable, and often debilitating condition that can have a significant impact on the daily lives of patients and their families,†said Michael Corbo.
Oct 27, 2020
This spray has been tested and proven for efficacy as well as fast action on the Covid19 virus by an independent accredited US-based lab.
Oct 27, 2020
ViiV Healthcare, today announced the positive findings of a pooled analysis of COVID-19-related impacts across the investigational long-acting cabotegravir and rilpivirine clinical development programme.
Oct 21, 2020
Pneumococcal disease in adults is on the rise globally, in part driven by disease-causing serotypes not targeted by the currently available pneumococcal conjugate vaccine
Oct 21, 2020
A pivotal Phase 3 trial of Dupixent met its primary and all key secondary endpoints in children aged 6 to 11 years with uncontrolled moderate-to-severe asthma
Oct 13, 2020
Novellus Therapeutics exclusively licenses induced mesenchymal stem cells (iMSCs) to NoveCite for COVID-19 related acute respiratory distress syndrome (ARDS) and other acute respiratory conditions
Oct 13, 2020
The initiation of the pivotal Phase 3 dosing study of giroctocogene fitelparvovec is a significant achievement for Pfizer as we continue our longstanding commitment to improving care for the hemophilia community
Oct 07, 2020
Positive pivotal trial data for the investigational use of PD-1 inhibitor Libtayo® (cemiplimab) in first-line locally advanced or metastatic non-small cell lung cancer (NSCLC) were shared in a presentation at the European Society for Medical Oncology (ESMO) Virtual Congress 2020.
Sep 21, 2020
Sanofi and GSK finalised and signed today an advanced purchase agreement with the European Commission (EC) for the supply of up to 300 million doses of a COVID-19 vaccine, once the vaccine is approved.
Sep 18, 2020
Fusion Health Care Pvt Ltd, a leading innovative pharmaceutical company based at Hyderabad, has announced the launch of its Favipiravir drug under the brand name XARAVIR, for the treatment of mild to moderate COVID-19 cases.
Aug 18, 2020
AveXis, which makes Novartis’s $2.1 million-per-patient gene therapy Zolgensma for the hereditary disease spinal muscular atrophy, is contributing technology, expertise and its manufacturing supply chain at no cost.
May 29, 2020
In a comparable viral assay study conducted by reputed laboratories in South Korea and United States, the drug, NLP21 has shown better viral inhibition ability than Remdesivir, Fevipiravir, Hydroxychloroquine, Lopinavir/Ritonavir etc.
May 16, 2020
Modish Care has launched truly customised Modish Protective Healthcare Kit for bulk orders, which include a set of Medical Coverall, Infrared Thermometer, Protective Eyeglass, Shoe Cover, Liquid Hand Wash, Hand Sanitizer, Office Sprayer, 10 Face Masks (3-ply and KN95) and 10 pairs of Hand Gloves
May 09, 2020
Retevmo is a selective RET kinase inhibitor. Retevmo may affect both tumor cells and healthy cells, which can result in side effects. Retevmo is an oral prescription medicine, 120 mg or 160 mg based on weight, taken twice daily until disease progression or unacceptable toxicity.
May 09, 2020
The University Medical Center Hamburg (UKE) has also increased its protective measures by using DERMALOG's Fever Detection Camera. The system of the German biometrics company measures body temperature within one second by scanning people's faces using state-of-the-art sensor technology.
May 08, 2020
Founded by Tushar Kumar and Prashant Singh in 2014, Medlife started with a simple thought of providing affordable and accessible healthcare services for all in the country .It began with providing services in just 85 pin codes in Bangalore and later expanded its operations in Mumbai, adding to 140 p
May 07, 2020
Aji Bio-Pharma provides high quality drug product aseptic fill finish services for CytoDyn. Leronlimab, a novel CCR5 antagonist with the potential for multiple therapeutic indications, has been and is currently being administered to COVID-19 patients at New York City area hospitals as part of an eme
May 06, 2020
Addressing the students, parents and the faculty at Swarnim Startup & Innovation University situated in Gandhinagar (Gujarat), in an online session, Union Minister of AYUSH, Shri Shripad Naik discussed various steps adopted by AYUSH Ministry to help the country fight COVID-19.
May 06, 2020
Hyundai Motor India Ltd., country’s first Smart Mobility Solutions Provider and the largest exporter since inception, has set Customer and Employee Safety as Top Priority with the announcement of a comprehensive list of measures, aimed at ensuring Dealership Preparedness
May 05, 2020
Morepen has recently launched a wide range of essential products being required to combat the growing menace of Coronavirus disease and to prevent further spread of this disease in the country. These include non-contact Infrared Thermometers, Hand Sanitizers, Hand Wash, Hand Rubs and Face Masks
May 02, 2020
TDCs are a first-in-class ADC with dual functionality. TRIO's dual action TDC utilizes targeted payload delivery to stop both tumor growth and immunosuppression. By generating a less immunosuppressive tumor microenvironment, TDC enhances activation of tumor-specific immune effector cells
May 01, 2020
"After having successfully developed the API and the formulations through its in-house R&D team, Glenmark is all geared to immediately begin clinical trials on Favipiravir on COVID-19 patients in India. The clinical trial will let us know the efficacy of this molecule on COVID-19 patients," said Sus
Apr 30, 2020
Glenmark Pharmaceuticals Ltd. (GPL) is a global research-led pharmaceutical company with presence across Generics, Specialty and OTC business with operations in over 50 countries. Glenmark's key therapy focus areas globally are respiratory, dermatology and oncology.
Apr 30, 2020
All in all, the Digital Health EMI Network Card offers great value for money, making finance one less thing to worry about when it comes to healthcare. To get started with a customized EMI financing deal, customers can check their pre-approved offer today.
Apr 29, 2020
Toyota Motor Corporation (Toyota) and Toyota Group companies are engaged in full-scale production of medical face shields in Japan, with Toyota largely expanding its production capacity from 500 to 600 units per week by approximately 20 times to start production of 40,000 units per month (approx)
Apr 28, 2020
Speaking about the need for preventive measures, Sunil Kataria CEO - India & SAARC, Godrej Consumer Products Limited (GCPL), said, "COVID-19 has caused high levels of panic. While we do our best to deal with this pandemic, we should not forget the looming threat of malaria and dengue.
Apr 27, 2020
According to health experts, coronavirus reduces the immune response of the infected person and it has been observed that this pandemic has mostly affected people with low immune system. The experts feel that improvement of the immune system helps in reducing the effects of the infection and also fi
Apr 27, 2020
The quality products being supplied by the company are gaining major traction across all marketing segments including online channels like Flipkart and Amazon. All the aforesaid products are available in all the geographical locations and are also being supplied to both private and government bodies
Apr 24, 2020
Due to shortage of ventilators, caretakers and medical staff uses bag valve mask devices to manually ventilate patients for prolonged periods of time leading to mortality and morbidity. To address this, Griffyn Robotech has developed affordable AI specilized ventilation devices to treat patients
Apr 23, 2020
The import of such drugs may be permitted after taking an undertaking from the importers by the port officers of CDSCO that the drug will be utilised or consumed before the expiry date and no part of it will be available for sale and distribution after its expiry
Apr 20, 2020
Tupperware as a brand believes in conserving, preserving and celebrating food, and all its solutions aid effective utilization of resources, including time, effort and food items - raw or cooked.
Apr 16, 2020
The VTA app – powered by learning and readiness platform provider Allego – connects respiratory therapists, nurses and other medical professionals with ventilator training resources from alliance member companies
Apr 16, 2020
BMW Group India has pledged INR 3 crore in the ongoing battle against COVID-19 pandemic. Associations with government and non-government organisations have been initiated for on-ground implementation in Delhi NCR and Chennai. Employees of BMW Group India, BMW Group Plant Chennai and BMW India Financ
Apr 16, 2020
Novartis has taken a lead in actively promoting heart failure awareness across India through unbranded digital initiatives that can successfully deliver message to a large population at risk.
Apr 16, 2020
This tracker aims to aid journalists as well as facilitate greater collaboration between researchers, policymakers, clinicians, journalists, philanthropists, and other critical stakeholders, and help them make pragmatic decisions on how to channel scarce resources.
Apr 09, 2020
West Pharmaceutical Services, Inc. , a global leader in innovative solutions for injectable drug administration, recently named Stewart Campbell as the Vice President & General Manager for the Asia Pacific region.
Apr 09, 2020
Asia-Pacific's largest specialist biotech CRO Novotech said the top 10 biotech sites in Australia were open for clinical trial activity with many sites modifying their practices to ensure continuity of operations.
Apr 09, 2020
OYO, one of the world’s leading hotel chains today announced two initiatives- ‘Donate A Night’ and ‘Book A Night for self-isolation’ to support the Government of India in its efforts to break the chain, flatten the curve and maintain the necessary nationwide lockdown.
Apr 07, 2020
The company has has received Emergency Use Authorization (EUA) by the US Food and Drug Administration for its TaqPathCOVID-19 Combo Kit for the qualitative detection of nucleic acid from SARS-CoV-2 in nasopharyngeal swab, nasopharyngeal aspirate, and bronchoalveolar lavage
Apr 06, 2020
This partnership is another step in the Foundation’s efforts to expand hospital and quarantine facilities and ensure proper medical treatment for the patients belonging to the economically weaker section of the society.
Apr 02, 2020
eal-time process management, location-based job tracking, the involvement of citizens, resource planning and management capabilities, which are part of the company's solutions for waste management and city cleaning processes, play a supportive role in managing this crisis situation.
Mar 30, 2020
The CHMP positive opinion will now be considered by the European Commission (EC). Once approved the EC will grant a centralized marketing authorization for member countries of the EU. The decision on the EC's approval is expected in May 2020.
Mar 28, 2020
In response to this unprecedented pandemic, NIIT Limited and its subsidiary, Eagle Productivity Solutions Inc. have developed a set of actionable roadmaps, toolkits and packaged services to help Learning and Development (L&D) organizations
Mar 27, 2020
Joe Kiani, Founder and CEO of Masimo, said, “We thank the nurses and doctors who are bravely toiling in hospitals taking care of us all during this pandemic.''
Mar 24, 2020
It is important for people to be aware that if they have a regular health insurance plan from any insurer paying for medical costs either through a cashless facility or reimbursement, all illnesses including Covid-19 are covered.
Mar 24, 2020
Lineage’s goal to help provide 100 million meals will include financial and in-kind donations facilitated by Lineage and its partners to Feeding America and other hunger-relief organizations.
Mar 24, 2020
Awareness and management are the keys to the safety of people. However, there are very few authentic sources of information such as the World Health Organization (WHO) and Centers of Disease Control and Prevention (CDC)That is one of the primary reasons Medvarsity took this initiative to educate peo
Mar 20, 2020
The study represents the data collection and analysis of a series of patients treated under an ongoing emergency compassionate use protocol. The study will investigate two cohorts retrospectively, hospitalised patients prior to admission to ICU or patients already requiring ICU
Mar 19, 2020
Vikor's testing has a 24-hour turn-around-time from sample arrival at the lab and can accurately detect over 40 pathogens known to cause Respiratory illness. Just as important, they have one of the largest antibiotic resistance gene panels on the commercial market.
Mar 16, 2020
The project also ensures the local farmers to get the benefit of additional income over and above their current earnings through sustainable cultivation measures like using of quality planting material and farming techniques like alternate and intercropping systems.
Mar 16, 2020
This test has not been FDA cleared or approved, however, the FDA can issue an EUA to permit use of certain medical products that may be effective in diagnosing, treating or preventing a disease or condition, as in the case of the novel coronavirus when the secretary of the U.S. Department of Health
Mar 14, 2020
Research well underway as Janssen scientists collaborate with leading virology laboratory led by Dan Barouch, M.D., Janssen is optimistic that, in collaboration with multiple global strategic partners, it can initiate a Phase 1 clinical study of a potential vaccine candidate by the end of the year.
Mar 14, 2020
CEO of BIOCON confirmed "We are extremely pleased with the U.S. court ruling in favour of our Insulin Glargine device as this takes us closer towards bringing a more affordable Insulin Glargine for patients with diabetes in the U. S.
Mar 12, 2020
Biocon and Mylan’s proposed biosimilar bevacizumab is expected to be the third biosimilar from the partnered portfolio for the cancer patients in the U.S. It is currently available in India and other developing markets.
Mar 12, 2020
“Parkinson's disease and Alzheimer's disease are caused by the degeneration and death of the cells in the brain. But once the cells with prestin gene fragments have been transplanted into the target area, ultrasound can be applied to awaken atrophied cells.
Mar 12, 2020
Swisse has a wide range of products, many using vegetarian formulations targeted to support specific health functions, as well as products using local Ayurvedic ingredients, such as Indian turmeric. The brand is particularly known for its vitamins, herbal and mineral supplements.
Mar 09, 2020
The highly qualified and experienced multi-organ Transplant team of Jupiter Hospital, Pune performed yet another high-end procedure which brings in hope for patients suffering from short gut syndrome.
Mar 09, 2020
The campaign showcases doctors from the Jaipur unit of Manipal Hospitals holding up placards which read quirky messages like "Our handwriting is readable, ask your pharmacist" and "Stop getting scared of injections". Putting doctors at the core of the campaign truly champions them as change makers
Mar 06, 2020
MoHAP and First Abu Dhabi Bank (FAB) sign an agreement to Enhance Patient-Centric Strategic Partnerships. The agreement aims to provide cash liquidity to Emirati patients and their escorts who are seeking medical treatment abroad in the countries where the treatment service is provided.
Mar 05, 2020
Nearly one-third of India suffers from a thyroid disorder. Women are eight times more likely to develop a thyroid disorder than men other common ailments are PCOS and menopausal problems
Mar 05, 2020
One of the oldest and the most renowned homeopathy clinic of Delhi/NCR has issued a ground-breaking 5 million prescriptions ever since its inception in 1977. More than 80% (approximately 4 million) prescriptions have been issued during charitable hours of the clinic
Mar 04, 2020
Each year, Frost & Sullivan presents a Company of the Year award to the organization that demonstrates excellence in terms of growth strategy and implementation in its field. The award recognizes a high degree of innovation with products and technologies resulting in leadership position
Mar 04, 2020
This partnership between UTS and Aragen unites the capabilities, experience, and expertise of two leading organizations to assist the Australian biopharma and biotech industries advance their ideas into medicines.
Mar 04, 2020
Deploying its suite of video meeting technology, seasoned video meeting specialists, and proprietary directory services during February, OpenExchange successfully connected 1500 professional investors with executive teams from more than 240 companies
Mar 03, 2020
Aster Volunteers, the corporate social responsibility (CSR) arm of Aster DM Healthcare handed over keys to home built for the flood victims of 2018 at an event held at Kochi Municipal Corporation Town Hall
Mar 03, 2020
European Medicines Agency (EMA) has adopted a positive opinion recommending granting marketing authorisation for nintedanib for the treatment of systemic sclerosis-associated interstitial lung disease (SSc-ILD) in adults
Mar 03, 2020
The WHO has spoken highly of China's contribution to disease prevention and control. "China's efforts have bought the world time - even though those steps have come at greater cost to China itself," said WHO Director-General Dr. Tedros Adhanom Ghebreyesus.
Mar 02, 2020
Lensme does not just focus on business, rather it realizes that there is more to life than accumulating sales and revenue, so Lensme strives to be a positive player in society through continuously sponsoring orphans and partnering with charities that help raise orphans and deal with orphan issues.
Mar 02, 2020
Under the terms of the agreement, Glenmark will be responsible for the continued development and regulatory approval of Ryaltrisâ„¢ by the US FDA, while Hikma will be responsible for the commercialization of Ryaltrisâ„¢ in the US.
Feb 28, 2020
Bajaj Finserv, is offering the Hospital Cash Cover which provides a daily cash allowance to take care of the day-to-day expenses. The daily cash benefit can also be availed if one is undergoing a day care treatment procedure.
Feb 27, 2020
Wipro Limited, a leading global information technology, consulting and business process services company, recently announced that it has been positioned as a ‘Leader’ in Everest Group’s Life Sciences Digital Services PEAK Matrix™ Assessment 2019, globally.
Feb 27, 2020
Investigational medicine TAK-062 is an oral computationally engineered super glutenase designed to improve the digestion of gluten. Successful “build to buy†relationship adds second investigational therapy to Takeda’s pipeline for the potential treatment of uncontrolled celiac disease
Feb 27, 2020
Dr. Nayak started his career as a physician in Bangalore, India and has an MBA in Marketing. He joined Takeda in 2011 and, since then, grew within the company to hold various senior international and regional roles.
Feb 26, 2020
A unique initiative which joins an innovative eyecare biopharma leader with international charities to train healthcare professionals to diagnose and treat patients with glaucoma
Feb 26, 2020
The use of Novalung as an ECMO device for critical care has several benefits, including minimizing the need for invasive ventilation, the ability to provide support after multi-organ injuries, and better survival outcomes for patients in cardiac arrest
Feb 25, 2020
The two companies will combine Honeywell’s deep expertise in process automation and controls technology with Bigfinite’s data analytics, artificial intelligence and machine learning platform, designed specifically for the biotechnology and pharmaceutical industries.
Feb 25, 2020
The Novartis Biome is a global network of innovation hubs aimed at strengthening the connection and interaction between Novartis and partners from across the digital ecosystem, from nimble startups and academia to the biggest players in the industry.
Feb 22, 2020
Before employee's return to work, Zoomlion set up an infection prevention and control team and a return-to-work plan to ensure the health and safety of returnees. To combat the infection, specialised teams disinfect the office site, production workshops and facilities, as well as roads, dormitories
Feb 22, 2020
Lilly is a global healthcare leader that unites caring with discovery to create medicines that make life better for people around the world. With this acquisition they continuing their important work to develop new therapeutic options for patients with chronic skin conditions.
Feb 22, 2020
The EC approval was based on findings from the Phase III HAWK and HARRIER clinical trials, in which Beovu met the primary endpoint, demonstrating gains in best corrected visual acuity (BCVA) that were non-inferior to aflibercept at year one (week 48).
Feb 22, 2020
Mumbai based Multi-Specialty Dr L H Hiranandani Hospital was recently conferred with the prestigious ‘Quality Beyond Accreditation’ Award at AHPI Global Conclave 2020 organized by an Association of Health Care Providers of India (AHPI).
Feb 21, 2020
Novartis has launched Novartis Biomed India at Hyderabad, aimed to boost connection & interaction among the various partners and company from across the digital ecosystem, from startups, academia to the biggest players in the industry.
Feb 21, 2020
Boehringer Ingelheim offers MyStudyWindow to provide patients, families, caregivers, and doctors consistent access to information about Boehringer Ingelheim’s actively recruiting studies conducted at global site locations
Feb 20, 2020
An accomplished scientific leader and industry veteran with over 25 years of experience in small molecule pharmaceutical process and product development, Dean Edney will split his time between the company's R&D centre in Hyderabad, India and the new R&D facility in Alderley Park, Manchester, UK.
Feb 20, 2020
Merck Foundation discussed their healthcare development and women empowerment programmes with The First Lady of Angola and also met the Minister of Health of Angola to discuss their healthcare capacity building program.
Feb 19, 2020
The bulk drugs (API) segment contributed around 58 per cent to the company’s total turnover in Q3' FY 2019-20. The company’s expanding domestic reach assisted in achieving a higher topline in Q3' FY 2019-20.
Feb 18, 2020
Aster DM Healthcare, one of the largest private healthcare service providers in multiple GCC states and an emerging healthcare player in India, announced its financial results for the quarter ended December 31, 2019.
Feb 14, 2020
Dr Reddy's Laboratories Ltd entered into a definitive agreement with Wockhardt Ltd to acquire select divisions of itsbranded generics business in India and a few other international territories, including Sri Lanka and Maldives for Rs 1850 crores, the drug maker said on Wednesday.
Feb 13, 2020
Five hospitals of Aster DM Healthcare group were recognised with the Association of Healthcare Providers India (AHPI) Awards 2020, which recently concluded in Bengaluru. The annual award by AHPI recognizes and celebrates the excellence achieved by healthcare organizations across various fields.
Feb 11, 2020
The said inspection was carried out from 24th June to 28th June 2019. At the end of the inspection, "No Objectionable Observation" was found and no Form 483 was issued.This new facility known as (T20) has already been approved by the other regulatory authorities like EU, TGA-Australia, Saphra-South
Feb 11, 2020
There are about 40 confirmed cases in Singapore, including 21 associated with import from China and 19 locally acquired with no history of travel, he said.The Singapore conference cluster has 12 cases associated with it. 5 in France, the 3 in Singapore itself, and then (South) Korea, Malaysia
Feb 11, 2020
Lupin Limited announced that it has received approval for its Leflunomide Tablets USP, 10 mg and 20 mg, from the United States Food and Drug Administration (U.S. FDA), to market a generic equivalent of Arava®Tablets,
Feb 10, 2020
Faithful to LAU Medical Center-Rizk Hospital's proposition and brand promise of healing with compassion, doctors decided to support the Lebanese community and launched the Act of Compassion initiative
Feb 08, 2020
Jabil combines Nypro with its Orthopedics, Spine, Trauma, and associated medical instruments businesses to deliver unmatched depth and breadth of advanced manufacturing solutions and innovative technical capabilities
Feb 05, 2020
As per CPCB estimates, there is 26,000 tonnes of plastic generated everyday in India of which 40% remains uncollected. GCPL and HICA Join Hands for an Initiative to Promote Plastic Waste Disposal of Household Insecticide Products
Feb 04, 2020
Bharti AXA General Insurance has received approval from the Insurance Regulatory and Development Authority of India (IRDAI) for its two insurance proposals under the regulatory Sandbox project.
Jan 22, 2020
With a joint focus on the delivery of better care through technology that can most effectively distill fractured, disparate health .data into actionable insights, Clarify Health and Leidos will co-develop a road map to address their current and new customers' unmet needs
Jan 14, 2020
Lupin Appoints Mr.J.Alan Butcher as Chief Corporate Development Officer, who will look after Lupin’s Global Corporate Development efforts and will be responsible for the Company’s Global M&A, Business Development and Licensing functions.
Jan 13, 2020
This High-End Skill Development Centre will function on the principle of “no-profit, no-loss†basis and has been primarily created to augment Government of India’s initiative for building skills in the area of Life Science.
Jan 13, 2020
The Ministry of Health and Prevention, MoHAP, has recently launched a training program for enhancing the scientific and practical capabilities and skills of 500 doctors from its cadres, to provide smoking cessation services in clinics
Jan 06, 2020
Today announced that the companies have entered into a global license agreement for Theravance Biopharma’s preclinical program for skin-targeted, locally-acting pan-Janus kinase (JAK) inhibitors that can be rapidly metabolized.
Dec 28, 2019
Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DR REDDY, NYSE: RDY, along with its subsidiaries together referred to as “Dr Reddy’sâ€) today announced the launch of Deferasirox Film-Coated Tablets, 90 mg and 360 mg, a therapeutically equivalent generic version of Jadenu
Dec 23, 2019
It is a value for money plan that offers a wide range of Sum Insured ranging between Rs. 1 lac to Rs. 30 lacs at an affordable premium amount Covers both Allopathic and AYUSH in-patient treatments up to Sum Insured Offers protection against medical inflation through Guaranteed Cumulative Bonus Guara
Dec 05, 2019
Pharma major Lupin Limited announced that its corporate social responsibility (CSR) arm, the Lupin Foundation won the prestigious award for ‘Excellence in Corporate Social Responsibility’ at the India Pharma Awards 2019 held in Greater Noida (National Capital Region).
Dec 05, 2019
Indian Council of Medical Research (ICMR), the apex body in India for health research signed a Declaration of Intent (DoI) with the National Institute of Allergy and Infectious Diseases (NIAD) of the National Institutes of Health, USA and the Bill & Melinda Gates Foundation (BMGF
Nov 30, 2019
Launched in the month of World Sight Day, this next-generation monofocal intraocular lens is an advanced solution for post cataract surgery patients, that helps to meet the changing lifestyle needs of patients
Oct 31, 2019
Cipla announces the acquisition of a novel and patented anti-infective product, Elores, from Venus Remedies Limited (“VRLâ€) for the Indian market to further strengthen its presence in the branded Indian critical care space and as a part of its agenda to contribute to the fight against Anti-Microbial
Oct 19, 2019
Merck Foundation organized their first “Merck Foundation Health Media Training†on 03rd October 2019 in Maseru, Lesotho in partnership with H.E. DR. MAESAIAH THABANE, The First Lady of the Kingdom of Lesotho and Ambassador of Merc.
Oct 07, 2019
-Advertisements-
.jpeg)
Tuesday, November 26, 2024
.png)
.png)
.png)
.png)
.png)